(Q33502576)

27 July 2017

title

Activity of paclitaxel by three-hour infusion in Asian patients with metastatic undifferentiated nasopharyngeal cancer (English)

1 reference

27 July 2017

1 reference

E Au

1

1 reference

27 July 2017

E H Tan

series ordinal

2

1 reference

27 July 2017

P T Ang

series ordinal

3

1 reference

27 July 2017

publication date

1 March 1998

1 reference

27 July 2017

1 reference

27 July 2017

volume

9

1 reference

27 July 2017

issue

3

1 reference

27 July 2017

page(s)

327-329

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008255220284

27 July 2017

1 reference

7 January 2021

Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008255220284

7 January 2021

Phase II trial of paclitaxel in patients with progressive ovarian carcinoma after platinum-based chemotherapy: a Gynecologic Oncology Group study.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008255220284

7 January 2021

Paclitaxel and recombinant human granulocyte colony-stimulating factor as initial chemotherapy for metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008255220284

7 January 2021

Phase II study of taxol, merbarone, and piroxantrone in stage IV non-small-cell lung cancer: The Eastern Cooperative Oncology Group Results

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008255220284

7 January 2021

Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008255220284

7 January 2021

Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008255220284

7 January 2021

High Complete Response in Advanced Nasopharyngeal Carcinoma With Bleomycin, Epirubicin, and Cisplatin Before Radiotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008255220284

7 January 2021

Paclitaxel in metastatic breast cancer: a trial of two doses by a 3-hour infusion in patients with disease recurrence after prior therapy with anthracyclines.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008255220284

7 January 2021

The integration of chemotherapy into a combined modality approached to cancer therapy. V. Squamous cell cancer of the head and neck

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008255220284

7 January 2021

Identifiers

DOI

10.1023/A:1008255220284

1 reference

27 July 2017

1 reference